Apply Now

Do you have a rectal cancer?

The CG-100 study is evaluating a new investigational treatment that may reduce the rate of diverting stoma and its related complications.

Qualified participants include:
  • Adults between 22 and 65 years of age.
  • Those who are undergoing colorectal surgery with a mesorectal excision and are planned to have a protecting diverting stoma as part of the operation.
  • Additional criteria apply

Those who qualify will receive treatment from a board-certified surgeon.

Please enter your Full Legal Name:

All information provided is confidential and will not be given or sold to any other agency without prior consent.
By clicking the “SUBMIT” button, I understand and agree to the Privacy Policy and Terms of Use. I agree to receive communication from the Colospan Contact Center regarding my inquiries. I understand that any services and information provided to me are supplied as a professional courtesy and are intended to assist me in forming my own conclusions and making my own decisions. I understand that any services and information provided to me are not to be construed as medical advice nor should it be used for diagnostic purposes. I Understand that with any medical related question I should also consult local medical sources.